Abstract
The present study provides evidence for a possible case of non-penetrance in Best's disease. We have analysed the at risk members of a three generation family with an established history of Best's disease by ophthalmoscopic examination, electrophysiological tests, and genetic analysis. The clinical examination identified 10 affected and five unaffected persons in this family. Genetic linkage analysis strongly supports linkage of the disease locus to DNA microsatellite markers from proximal llq. The genotyping data were used to construct the familial haplotype associated with Best's disease. One person was identified who has inherited the Best's disease haplotype from his affected mother. Fundus examination and electrophysiological tests have repeatedly been performed in this patient but failed to show any signs of the disease. Based on these findings we have jointly estimated the most likely order of the Best's disease locus relative to the closest flanking markers at various penetrance values. A maximum likelihood estimate for the heterozygote penetrance was reached for the locus order DllS903-Best's disease-PYGM at a penetrance value of 0-96. ( t Difference from penetrance value of 1 significant at the 5% level.
disease gene. Subject III.14 was assumed to be unaffected. We maximised the likelihood in all three pedigrees with respect to locus order and penetrance (table 3) . The highest -2lnL+ constant was reached for the order DI I S903-Best's disease-PYGM at a penetrance value of 0-96 (-2lnL + constant = 691 23). The highest -21nL + constant at a fixed penetrance value of 1 was obtained for the order Best's disease-Dl l S903-PYGM (-21nL + constant= 696-23). This difference is significant at the 5% level (X2 = 5 00, 1 df).
Discussion
In Best's disease a wide range in the expressivity of the defective gene has often been reported35 and is also evident in the family presented in this study. While two members of the family show fundus lesions characteristic of Best's disease, another eight asymptomatic persons were diagnosed as carriers of the disease gene based on electro-oculography (EOG). A subnormal and prolonged light rise of the EOG has repeatedly been found to be highly characteristic of Best's disease.781025
Taken together, the results from the clinical examinations and the electrophysiological tests clearly confirm the diagnosis of Best's disease in our family.
We have now identified one person in this pedigree who represents the first documented case of non-penetrance in Best's disease. Genetic analysis has shown that sib III.14 has inherited the Best's disease haplotype. On the other hand, fundus examinations and repeated EOG tests have not indicated any signs of the disease. By repeating the EOG test we have excluded the possibility that poor quality tracings or other factors might have influenced the diagnosis previously. In addition, the two recordings clearly document that no changes have occurred in the EOG tracings over the last five years. In Best's disease, it is generally accepted that the EOG abnormalities are evident in the first decade of life and only the time consuming recording procedure itself seems to be a major hindrance for obtaining good quality EOG tracings from very young patients. At his last EOG test III.14 was 37 years of age. To our knowledge, there are no published cases with onset of the EOG abnormalities in the third or fourth decade of life.
Interestingly, 111.14 and his affected mother both had slightly abnormal colour vision. It could be argued that this abnormality represents a clinical manifestation of affectedness in our family. However, colour vision in the affected sister of III.14 is in the normal range. In addition, colour defects in Best's disease patients are generally proportional to the degree of visual loss and have, to our knowledge, never been reported in unaffected carriers. It, therefore, appears highly questionable whether the colour vision defect in our family is causally linked to the Best's disease locus. More likely, this defect might segregate as an independent trait in the family.
The evidence for non-penetrance in our study is based on genetic analysis and relies upon the fact that in our family the Best's disease locus is linked to proximal llq. In many hereditary retinal degeneration disorders genetic heterogeneity seems to be a common phenomenon, for example, autosomal dominant retinitis pigmentosa. The possibility of a double crossing over between markers at D11S903 and PYGM should also be considered. In this case III.14 would carry the normal gene on the Best's disease haplotype. However, this possibility has been refuted by the likelihood ratio test. Instead it is statistically significant to assume a reduced penetrance value of 0 96. The absolute value of 0 96 may even be an overestimate owing to a bias towards the collection of affected persons in the ascertainment of Best's disease families. The definite proof that III.14 is a carrier of the Best's disease gene but is not expressing the disease will have to await the molecular characterisation of the mutation. However, our study strongly suggests that the clinical examination and, more importantly, the electro-oculogram (EOG) may not identify all carriers of the Best's disease gene. This may have important consequences for the genetic counselling of at risk persons. 
